Skip to content

The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy

Skeletal Muscle Blood Flow in Becker Muscular Dystrophy

Status
Terminated
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02653833
Enrollment
6
Registered
2016-01-12
Start date
2017-11-01
Completion date
2018-09-01
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscular Dystrophy

Keywords

Becker, Muscular Dystrophy, Skeletal Muscle, blood flow, Ultrasound

Brief summary

This pilot study tests the hypothesis that the medication nitric oxide extract from beetroot juice improves blood flow to the skeletal muscle during exercise. The investigators will use cutting edge technology with contrast enhanced ultrasound to visualize the microvascular blood supply to the forearm. Animal studies have shown reversal of muscle damage with improved delivery of blood to the exercising muscle. This research aims to understand the mechanism of action of this medication in a way it has never been studied before. The results may help benefit individuals with muscular Dystrophy in the future.

Detailed description

The subjects are asked to perform a graded hand-grip exercise while blood flow to the skeletal muscle is visualized by contrast enhanced ultrasound. This is done at baseline and after taking the study agent.

Interventions

OTHERbeetroot juice extract

Blood flow to the forearm is visualized via an ultrasound technique at rest and with graded exercise. The experiment is then repeated shortly after the subject takes the study agent, beetroot juice extract.

Blood flow to the forearm is visualized via an ultrasound technique at rest and with graded exercise. The experiment is then repeated shortly after the subject takes the study agent, beetroot juice extract.

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy man, aged 18 to 45 years, currently taking no medication. OR * Clinical diagnosis of Becker Muscular Dystrophy (BMD), aged 18 to 45 years, and currently taking no medication.

Exclusion criteria

* Hypertension, diabetes, heart failure, liver disease * ECG evidence of prolonged QT interval

Design outcomes

Primary

MeasureTime frameDescription
Change in Skeletal Muscle Blood FlowAt baseline and within one hours after taking beetroot juice or TadalafilExercise induced skeletal muscle perfusion is measured by contrast-enhanced ultrasound (CEU) during graded voluntary contraction on a hand grip dynamometer.

Secondary

MeasureTime frameDescription
Change in Measured Functional SympatholysisAt baseline, and within an hour after taking beetroot juice or TadalafilFunctional sympatholysis (attenuation of exercise induced skeletal muscle vasoconstriction) is assessed using a lower body negative pressure chamber.
Change in Measured Flow Mediated Dilation (FMD)At baseline, and within an hour after taking beetroot juice or TadalafilEndothelial function is assessed by measuring flow-mediated dilation (FMD) by Doppler ultrasound.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026